Celldex (NASDAQ: CLDX) reported Q3 EPS of ($0.29), $0.04 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $850 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.